Неинфекционное воспалительное поражение аорты и крупных артерий

Обложка

Цитировать

Полный текст

Аннотация

Рассматриваются различные формы воспалительного поражения аорты и крупных артерий, включая хронический периаортит, а также методы их диагностики. К наиболее распространенным относятся васкулиты крупных сосудов, вместе с тем поражение аорты и крупных артерий возможно при различных других ревматических и воспалительных заболеваниях, вследствие лекарственной или паранеопластической реакции. Решающее значение для уточнения фазы болезни и определения тактики лечения принадлежит визуализации с помощью инструментальных методов обследования.

Об авторах

Татьяна Валентиновна Бекетова

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента РФ; ФГАОУ ВО «Московский политехнический университет»

Автор, ответственный за переписку.
Email: tvbek@rambler.ru
ORCID iD: 0000-0003-2641-9785

д-р мед. наук, вед. науч. сотр. ФГБНУ «НИИ ревматологии им. В.А. Насоновой», зав. отд-нием ревматологии с нефрологическими койками и кабинетом терапии генно-инженерными биологическими препаратами ФГБУ «ЦКБ с поликлиникой», проф. каф. инфокогнитивных технологий ФГАОУ ВО «Московский политехнический университет»

Россия, Москва; Москва; Москва

Список литературы

  1. Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology. 2011;261(2):625-33. doi: 10.1148/radiol.11102250
  2. Park SH, Im CH, Yang DH, et al. A case of chronic periaortitis with retroperitoneal fibrosis. Korean Circ J. 2012;42(12):857-60. doi: 10.4070/kcj.2012.42.12.857
  3. Fujimori N, Ito T, Igarashi H, et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol. 2013;19(1):35-41. doi: 10.3748/wjg.v19.i1.35
  4. Rojo-Leyva F, Ratliff NB, Cosgrove III DM, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43(4):901-7. doi: 10.1002/1529-0131(200004)43:4<901::AIDANR23>3.0.CO;2-U
  5. De Martino A, Ballestracci P, Faggioni L, et al. Incidence of aortitis in surgical specimens of the ascending aorta clinical implications at follow-up. Semin Thorac Cardiovasc Surg. 2019;31(4):751-60. doi: 10.1053/j.semtcvs.2018.10.022
  6. Miller DV, Isotalo PA, Weyand CM, et al. Surgical pathology of noninfectious ascending aortitis: A study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006;30(9):1150-8. doi: 10.1097/01.pas.0000213293.04026.ec
  7. Blockmans D, Ceuninck Ld, Vanderschueren S, et al. Repetitive 18F-fluorodeoxy-glucose positron-emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum. 2006;55(1):131-7. doi: 10.1002/art.21699
  8. Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large-vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636-43. doi: 10.1136/annrheumdis-2017-212649
  9. Rosero EB, Peshock RM, Khera A, et al. Sex, race, and age distributions of mean aortic wall thickness in a multiethnic population-based sample. J Vasc Surg. 2011;53(4):950-7. doi: 10.1016/j.jvs.2010.10.073
  10. Jennette JC, Falk R, Bacon P, et al. 2012 Revised international Chapel Hill Consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1-11. doi: 10.1002/art.37715
  11. Adiga GU, Elkadi D, Malik SK, et al. Abdominal aortitis after use of granulocyte colony-stimulating factor. Clin Drug Investig. 2009;29(12):821-5. doi: 10.2165/11530790-000000000-00000
  12. Oshima Y, Takahashi S, Tani K, Tojo A. Granulocyte colony-stimulating factor-associated aortitis in the japanese adverse drug event report database. Cytokine. 2019;119:47-51. doi: 10.1016/j.cyto.2019.02.013
  13. Darie C, Boutalba S, Fichter P, et al. Aortite après injections de G-CSF [Aortitis after G-CSF injections]. Rev Med Interne. 2004;25(3):225-9. doi: 10.1016/j.revmed.2003.10.015
  14. Koyama Y, Adachi K, Yagi M, et al. Successful treatment of G-CSF- related aortitis with prednisolone during preoperative chemotherapy for breast cancer: a case report. Surg Case Rep. 2021;7:23. doi: 10.1186/s40792-021-01111-z
  15. Hiranuma K, Kusunoki S, Fujino K, et al. Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy. Taiwan J Obstet Gynecol. 2018;57(5):750-2. doi: 10.1016/j.tjog.2018.08.026
  16. Tanaka H, Kondo E, Kawato H, et al. Aortitis during intraarterial chemotherapy for cervical cancer. Int J Clin Oncol. 2002;7(1):62-5. doi: 10.1007/s101470200008
  17. O’Connell EW, Reams J, Denio AE. Aortitis as a Harbinger of Occult Malignancy. Case Rep Rheumatol. 2019;2019:8385630. doi: 10.1155/2019/8385630
  18. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl. 1992;7:11-7. doi: 10.1007/BF01744538
  19. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919-29. doi: 10.7326/0003-4819-120-11-199406010-00004
  20. Gornik HL, Creager MA. Aortitis. Circulation. 2008;117(23):3039-51. doi: 10.1161/CIRCULATIONAHA.107.760686
  21. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33:1074-87. doi: 10.1002/art.1780330804
  22. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995;24(6):422-31. doi: 10.1016/s0049-0172(95)80010-7
  23. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48(5):1014-27. doi: 10.1161/01.cir.48.5.1014
  24. Hull RG, Asherson RA, Rennie JA. Ankylosing spondylitis and an aortic arch syndrome. Br Heart J. 1984;51(6):663-5. doi: 10.1136/hrt.51.6.663
  25. Loricera J, Blanco R, Hernández JL, et al. Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review. Clin Exp Rheumatol. 2015;33(2 Suppl. 89):S19-31.
  26. Cochrane AD, Tatoulis J. Cogan's syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenoses. Ann Thorac Surg. 1991;52(5):1166-7. doi: 10.1016/0003-4975(91)91304-e
  27. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore). 1980;59(6):426-41.
  28. Singer O. Cogan and Behcet syndromes. Rheum Dis Clin North Am. 2015;41(1):75-91. doi: 10.1016/j.rdc.2014.09.007
  29. Slobodin G, Naschitz JE, Zuckerman E, et al. Aortic involvement in rheumatic diseases. Clin Exp Rheumatol. 2006;24(2 Suppl. 41):41–S47.
  30. Giordano M, Valentini G, Sodano A. Relapsing polychondritis with aortic arch aneurysm and aortic arch syndrome. Rheumatol Int. 1984;4(4):191-3. doi: 10.1007/BF00541214
  31. Manna R, Annese V, Ghirlanda G, et al. Relapsing polychondritis with severe aortic insufficiency. Clin Rheumatol. 1985;4(4):474-80. doi: 10.1007/BF02031904
  32. Dib C, Moustafa SE, Mookadam M, et al. Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin Proc. 2006;81(6):772-6. doi: 10.4065/81.6.772
  33. Selim AG, Fulford LG, Mohiaddin RH, Sheppard MN. Active aortitis in relapsing polychondritis. J Clin Pathol. 2001;54(11):890-2. doi: 10.1136/jcp.54.11.890
  34. Miyake T, Yokoyama T, Shinohara T, et al. Transient dilatation of the abdominal aorta in an infant with Kawasaki disease associated with thrombocytopenia. Acta Paediatr Jpn. 1995;37:521-5. doi: 10.1111/j.1442-200x.1995.tb03368.x
  35. Chikamori T, Doi YL, Yonezawa Y, et al. Aortic regurgitation secondary to Behcet’s disease: a case report and review of the literature. Eur Heart J. 1990;11:572-6. doi: 10.1093/oxfordjournals.eurheartj.a059752
  36. Willett WF III, Kahn MJ, Gerber MA. Lupus aortitis: a case report and review of the literature. J La State Med Soc. 1996;148:55-9.
  37. Guard RW, Gotis-Graham I, Edmonds JP, Thomas AC. Aortitis with dissection complicating systemic lupus erythematosus. Pathology. 1995;27:224-8. doi: 10.1080/00313029500169023
  38. Breynaert C, Cornelis T, Stroobants S, et al. Systemic lupus erythematosus complicated with aortitis. Lupus. 2008;17(1):72-4. doi: 10.1177/0961203307084172
  39. Kurata A, Kawakami T, Sato J, et al. Aortic aneurysms in systemic lupus erythematosus: a meta-analysis of 35 cases in the literature and two different pathogeneses. Cardiovasc Pathol. 2011;20(1):e1-7. doi: 10.1016/j.carpath.2010.01.003
  40. Gravallese EM, Corson JM, Coblyn JS, et al. Rheumatoid aortitis: a rarely recognized but clinically significant entity. Medicine (Baltimore). 1989;68:95-106.
  41. Hoshina K, Koyama H, Miyata T, et al. Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm. J Vasc Surg. 2004;40(3):512-8. doi: 10.1016/j.jvs.2004.06.018
  42. Smith DC, Hirst AE. Spontaneous aortic rupture associated with chronic steroid therapy for rheumatoid arthritis in two cases. AJR Am J Roentgenol. 1979;132(2):271-3. doi: 10.2214/ajr.132.2.271
  43. Rose CD, Eichenfield AH, Goldsmith DP, Athreya BH. Early onset sarcoidosis with aortitis – “juvenile systemic granulomatosis?”. J Rheumatol. 1990;17(1):102-6.
  44. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539-51. doi: 10.1056/NEJMra1104650
  45. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;85(9976):1460-71. doi: 10.1016/S0140-6736(14)60720-0
  46. Blockmans D, Baeyens H, Van Loon R, et al. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol. 2000;19(2):161-4. doi: 10.1007/s100670050038
  47. Carels T, Verbeken E, Blockmans D. p-ANCA-associated periaortitis with histological proof of Wegener's granulomatosis: case report. Clin Rheumatol. 2005;24(1):83-6. doi: 10.1007/s10067-004-0998-0
  48. Haug ES, Skomsvoll JF, Jacobsen G, et al. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg. 2003;38(3):492-7. doi: 10.1016/s0741-5214(03)00340-9
  49. Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis. A prospective study. Am J Med. 2003;114(6):454-62. doi: 10.1016/s0002-9343(03)00056-1
  50. Schirmer M, Duftner C, Seiler R, et al. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis? Curr Opin Rheumatol. 2006;18(1):48-53. doi: 10.1097/01.bor.0000198001.35203.36
  51. Ghinoi A, Pipitone N, Boiardi L, et al. Primary Sjogren's syndrome associated with chronic periaortitis. Rheumatology (Oxford). 2007;46(4):719-20. doi: 10.1093/rheumatology/kel452
  52. Васильев В.И., Сокол Е.В., Кокосадзе Н.В., и др. Дифференциальная диагностика болезни Эрдгейма–Честера и заболеваний, связанных с IgG4. Терапевтический архив. 2016;88(5):70-6 [Vasilyev VI, Sokol EV, Kokosadze NV, et al. The differential diagnosis of Erdheim–Chester disease and IgG4-related diseases. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(5):70-6 (in Russian)]. doi: 10.17116/terarkh201688570-76
  53. Inoue M, Nakagomi H, Nakada H, et al. Periaortitis induced by epirubicin and cyclophosphamide for a patient with advanced breast cancer. Int Cancer Conf J. 2017;6(4):180-3. doi: 10.1007/s13691-017-0302-1
  54. Murakami S, Saito H, Ohe M, et al. Periaortitis associated with anti-neutrophil cytoplasmic antibodies induced by bevacizumab combination therapy. Intern Med. 2013;52(5):589-91. doi: 10.2169/internalmedicine.52.6632
  55. D’Alpino Peixoto R, Al-Barrak J, Lim H, Renouf D. Gastroesophageal cancer and retroperitoneal fibrosis: two case reports and review of the literature. World J Gastroinest. Oncol. 2013;5(3):68-70. doi: 10.4251/wjgo.v5.i3.68
  56. Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: A population-based study. Ann Intern Med. 1995;122(7):502-7. doi: 10.7326/0003-4819-122-7-199504010-00004
  57. Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant cell arteritis: A population-based cohort study of the incidence–trends and prognosis. Ann Rheum Dis. 2013;72(12):1989-94. doi: 10.1136/annrheumdis-2012-202408
  58. Kim H, Barra L. Ischemic complications in takayasu’s arteritis: A meta-analysis. Semin Arthritis Rheum. 2018;47(6):900-6. doi: 10.1016/j.semarthrit.2017.11.001
  59. Sreih AG, Alibaz-Oner F, Kermani TA, et al. Development of a core set of outcome measures for large-vessel vasculitis: Report from OMERACT 2016. J Rheumatol. 2017;44(12):1933-7. doi: 10.3899/jrheum.161467
  60. Hunder GG, Bloch DA, Michel BA, et al. The American College of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122-8. doi: 10.1002/art.1780330810
  61. Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron-emission tomography in patients with large-vessel vasculitis: A systematic review. Clin Rheumatol. 2011;30(10):1265. doi: 10.1007/s10067-011-1828-9
  62. Salvarani C, Cantini F, Boiardi L, Hunder G. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol. 2003;21(6 Suppl. 32):23-8.
  63. Xenitidis T, Horger M, Zeh G, et al. Sustained inflammation of the aortic wall despite tocilizumab treatment in two cases of Takayasu arteritis. Rheumatology (Oxford). 2013;52(9):1729-31. doi: 10.1093/rheumatology/ket107
  64. Spira D, Xenitidis T, Henes J, Horger M. MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study. Br J Radiol. 2016;89(1058):20150892. doi: 10.1259/bjr.20150892
  65. Benhuri B, ELJack А, Kahaleh B, Chakravarti R. Mechanism and biomarkers in aortitis – a review. J Mol Med. 2020;98(1):11-23. doi: 10.1007/s00109-019-01838-1
  66. Diamantopoulos AP, Haugeberg G, Hetland H, et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res. 2014;66:113–9. doi: 10.1002/acr.22178
  67. Germanò G, Monti S, Ponte C, et al. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol. 2017;35 Suppl. 103(1):194-98.
  68. De Miguel E, Roxo A, Castillo C, et al. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol. 2012;30:34-8.
  69. Habib HM, Essa AA, Hassan AA. Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol. 2012;31:231-7. doi: 10.1007/s10067-011-1808-0
  70. Pipitone N, Versari A, Hunder GG, Salvarani C. Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am. 2013;39:593-608. doi: 10.1016/j.rdc.2013.02.002
  71. Prieto-González S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol. 2015;27:53-62. doi: 10.1097/BOR.0000000000000130
  72. Lariviere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. Medicine. 2016;95:e4146. doi: 10.1097/MD.0000000000004146
  73. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246-9. doi: 10.1016/s0002-9343(99)00424-6
  74. Puppo C, Massollo M, Paparo F, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. Biomed Res Int. 2014;2014:1-11. doi: 10.1155/2014/574248
  75. Bucci M, Aparici CM, Hawkins R, et al. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). J Neuroimaging. 2014;24(2):117-23. doi: 10.1111/j.1552-6569.2012.00740.x
  76. Mavrogeni S, Dimitroulas T, Chatziioannou SN, et al. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2013;42:401-12. doi: 10.1016/j.semarthrit.2012.07.005
  77. Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: State of the art. Best Pract Res Clin Rheumatol. 2016;30(4):688-706. doi: 10.1016/j.berh.2016.09.010
  78. Paul JF, Fiessinger JN, Sapoval M, et al. Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr. 2001;25:924-31. doi: 10.1097/00004728-200111000-00015
  79. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998;209:103-9. doi: 10.1148/radiology.209.1.9769819
  80. Li D, Lin J, Yan F. Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. J Comput Assist Tomogr. 2011;35:468-74. doi: 10.1148/radiology.209.1.9769819
  81. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574-8. doi: 10.1002/art.23699
  82. Zhang B, Liang L, Chen W, et al. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One. 2015;10:e0129720. doi: 10.1371/journal.pone.0129720
  83. Kanda T, Nakai Y, Hagiwara A, et al. Distribution and chemical forms of gadolinium in the brain: a review. Br J Radiol. 2017;90:20170115. doi: 10.1259/bjr.20170115

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать
2. Рис. 1. Селективная ангиопульмонография у пациентки с АТ: субтотальный стеноз в устьях и проксимальных сегментах верхнедолевой и нижнедолевой ветвей правой легочной артерии (стрелки).

Скачать (177KB)
Метаданные

© ООО "Консилиум Медикум", 2022

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах